| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,098 |
2,499 |
$189K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,245 |
1,088 |
$120K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,543 |
1,375 |
$45K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
711 |
606 |
$43K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
579 |
464 |
$30K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
372 |
313 |
$26K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
128 |
125 |
$13K |
| 90461 |
|
592 |
568 |
$8K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
574 |
528 |
$5K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
303 |
289 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
514 |
199 |
$2K |
| H0049 |
Alcohol and/or drug screening |
109 |
102 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
20 |
20 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
32 |
32 |
$613.32 |
| 99188 |
|
51 |
50 |
$596.43 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
48 |
38 |
$578.41 |
| 96160 |
|
552 |
449 |
$574.60 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
92 |
64 |
$335.74 |
| 87807 |
|
61 |
58 |
$279.86 |
| 96127 |
|
349 |
263 |
$277.14 |
| 85018 |
|
197 |
167 |
$174.47 |
| 1160F |
|
4,857 |
4,037 |
$146.36 |
| 83718 |
|
12 |
12 |
$47.50 |
| 83655 |
|
13 |
12 |
$37.62 |
| 82465 |
|
12 |
12 |
$32.72 |
| 96161 |
|
191 |
120 |
$32.52 |
| 90677 |
|
87 |
85 |
$24.01 |
| 90686 |
|
120 |
119 |
$17.97 |
| 3725F |
|
1,465 |
1,191 |
$0.00 |
| 3078F |
|
1,775 |
1,329 |
$0.00 |
| 90670 |
|
212 |
151 |
$0.00 |
| 90633 |
|
69 |
40 |
$0.00 |
| 99072 |
|
83 |
76 |
$0.00 |
| 3074F |
|
1,782 |
1,371 |
$0.00 |
| 1036F |
|
2,044 |
1,469 |
$0.00 |
| 99174 |
|
1,253 |
1,037 |
$0.00 |
| 3008F |
|
4,028 |
3,232 |
$0.00 |
| 36416 |
|
211 |
183 |
$0.00 |
| 90698 |
|
91 |
68 |
$0.00 |
| 92551 |
|
160 |
142 |
$0.00 |
| 90651 |
|
42 |
42 |
$0.00 |
| 90744 |
|
61 |
37 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
34 |
32 |
$0.00 |
| 90680 |
|
59 |
38 |
$0.00 |
| 90619 |
|
12 |
12 |
$0.00 |
| 99000 |
|
33 |
32 |
$0.00 |